Neuroprotection in brain ischemia–doubts and hopes

Ideggyogyaszati szemle

In ischaemic stroke the two major potential therapeutic strategies are aimed at either improving cerebral blood flow or directly interacting with the cytotoxic cascade–a large body of evidence gained from animal studies is in support of them. In clinical trials direct neuroprotection by blocking the neurotoxic cascade remained ineffective, although there are several clinical trials still in progress. We summarize the experimental data and present the results of clinical trials and also discuss…

Released at: 23.09.2020, written by webmaster_popp

Partners